Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Her2 Trastuzumab'

Her2 Trastuzumab published presentations and documents on DocSlides.

HER2 TESTING IN BREAST CANCER

HER2 TESTING IN BREAST CANCER

  • danika-pritchard
  • 32 Slides

Clinical Practice Guideline Update. American Soci...

HER2 TESTING IN BREAST CANCER

HER2 TESTING IN BREAST CANCER

  • danika-pritchard
  • 0 Slides

Clinical Practice Guideline Update. American Soci...

Updates on the Use of Adjuvant Therapy in HER2-Positive Breast Cancer

Updates on the Use of Adjuvant Therapy in HER2-Positive Breast Cancer

  • danika-pritchard
  • 0 Slides

ASCO-CAP Recommendations For HER2 Testing in Brea...

HER2 and Ki67Assessment of regional lymph nodesPhysical examination

HER2 and Ki67Assessment of regional lymph nodesPhysical examination

  • arya
  • 28 Slides

Luminal B-like (HER2-positive):!ER-positive!HER2-p...

What’s new in Anatomic Pathology Quality Assurance?

What’s new in Anatomic Pathology Quality Assurance?

  • alida-meadow
  • 59 Slides

. Raouf E. Nakhleh, MD. Mayo Clinic Florida. Dis...

Tumor Marker Phenotype Concordance in Second Primary Breast Cancer

Tumor Marker Phenotype Concordance in Second Primary Breast Cancer

  • debby-jeon
  • 0 Slides

Monica Brown, MPH, PhD. . California Cancer Regi...

Metastatic Breast Cancer: A Medical Update

Metastatic Breast Cancer: A Medical Update

  • liane-varnes
  • 0 Slides

Jennifer M. Matro, MD. Rena Rowan Breast Center. ...

Endocrine resistance: molecular pathways and rational development of targeted therapies

Endocrine resistance: molecular pathways and rational development of targeted therapies

  • spottletoefacebook
  • 66 Slides

Grazia Arpino. Università di Napoli Federico II. ...

Product Pipeline Neratinib

Product Pipeline Neratinib

  • coursion
  • 1 Slides

across the breast cancer therapy spectrum. Phase I...

6'DakoHercepTestTM for the Dako AutostainerCode K52071st editionFor im

6'DakoHercepTestTM for the Dako AutostainerCode K52071st editionFor im

  • katrgolden
  • 50 Slides

Contents PageIntended Use 4Summary and Explanation...

Snyder D, Heidel RE, Panella T, Bell J, Orucevic

Snyder D, Heidel RE, Panella T, Bell J, Orucevic

  • Kingslayer
  • 19 Slides

A. University of Tennessee Medical Center – Knox...

Nanotek & Expo 2014

Nanotek & Expo 2014

  • DaintyLittlePrincess
  • 16 Slides

Biodegradable . nanobrushes. for drug delivery. ...

ORIGINALARTICLEBREASTONCOLOGY

ORIGINALARTICLEBREASTONCOLOGY

  • emery
  • 8 Slides

SentinelLymphNodeBiopsyAfterNeoadjuvantChemotherap...

Central Asian Journal of

Central Asian Journal of

  • cady
  • 10 Slides

15 Medical and Pharmaceutical Sciences Innovation ...

Denise A. Yardley, MD Sarah Cannon Research Institute

Denise A. Yardley, MD Sarah Cannon Research Institute

  • lily
  • 29 Slides

Senior Investigator, . Breast Cancer Research. Ten...

CA BREAST D r S ana

CA BREAST D r S ana

  • oconnor
  • 68 Slides

ishtiaq. . FCPS R3 general surgery unit one UKSO...

Changes in Breast Cancer Reports After Second Opinion

Changes in Breast Cancer Reports After Second Opinion

  • unita
  • 31 Slides

Dr. Vicente Marco. Department of Pathology. Hospit...

2020 Year in Review: Breast Cancer

2020 Year in Review: Breast Cancer

  • caroline
  • 43 Slides

Lisa A. Carey MD, . ScM. University of North Carol...

Translating NGS Data into a Clinically Actionable Assay

Translating NGS Data into a Clinically Actionable Assay

  • danika-pritchard
  • 41 Slides

Elaine R. Mardis, Ph.D.. Professor of Genetics. C...

Evaluation of HR[ER/

Evaluation of HR[ER/

  • debby-jeon
  • 60 Slides

PgR. ] status and correlation with Ki67 expres...

Chemotherapeutic Treatment Options for Triple Negative Brea

Chemotherapeutic Treatment Options for Triple Negative Brea

  • lois-ondreau
  • 31 Slides

Lauren Barney. April 17, 2013. Breast Cancer Subt...

RESEARCHARTICLEOpenAccess

RESEARCHARTICLEOpenAccess

  • alida-meadow
  • 100 Slides

Proposednewclinicopathologicalsurrogate definition...

At the Forefront of Immunotherapy

At the Forefront of Immunotherapy

  • karlyn-bohler
  • 20 Slides

OTCQB: TPIV. 1551 Eastlake Ave E. Suite 100. Seat...

Chemotherapeutic Treatment Options for Triple Negative Brea

Chemotherapeutic Treatment Options for Triple Negative Brea

  • alida-meadow
  • 30 Slides

Lauren Barney. April 17, 2013. Breast Cancer Subt...

Metastatic Breast Cancer

Metastatic Breast Cancer

  • lindy-dunigan
  • 36 Slides

A sub-focus on specific clinical scenarios. What ...

RCR breast radiotherapy consensus guidelines

RCR breast radiotherapy consensus guidelines

  • karlyn-bohler
  • 9 Slides

Producing the guidelines. Draft radiotherapy guid...

Evaluation of HR[ER/ PgR

Evaluation of HR[ER/ PgR

  • pasty-toler
  • 0 Slides

] status and correlation with Ki67 expression ...

Genomic/Genetic Testing Germline v Somatic testing and the importance of Molecular Tumor Boards

Genomic/Genetic Testing Germline v Somatic testing and the importance of Molecular Tumor Boards

  • lois-ondreau
  • 0 Slides

Ben Ho Park MD PhD. Johns Hopkins University. Fin...

update in metastatic breast cancer

update in metastatic breast cancer

  • calandra-battersby
  • 0 Slides

. Dr.Mina. . Tajvidi. Radiation . oncologist. ...

CDK 4/6 Inhibitors in Breast Cancer Expert Perspectives on New Data

CDK 4/6 Inhibitors in Breast Cancer Expert Perspectives on New Data

  • min-jolicoeur
  • 22 Slides

CDK 4/6 Inhibitors in Breast Cance...

Endocrine Treatment of Metastatic Breast Cancer: New Advances; Patient Education Implications

Endocrine Treatment of Metastatic Breast Cancer: New Advances; Patient Education Implications

  • calandra-battersby
  • 74 Slides

An Interactive Oncology Grand Rounds Series. Joyc...

Moving Evidence into Practice: Breast Cancer Highlights From Chicago

Moving Evidence into Practice: Breast Cancer Highlights From Chicago

  • alida-meadow
  • 28 Slides

This program will include a discussion of off-lab...

Brea st cancer G eneral

Brea st cancer G eneral

  • slayrboot
  • 89 Slides

. in. f. orma. t. ion. Risk. . f. a. ct. ors. Pro...

A case of localized breast cancer

A case of localized breast cancer

  • envrrolex
  • 21 Slides

Antonella Brunello . Kwok-Leung Cheung. Disclosure...

TARGETED CANCER THERAPY IN 2016:

TARGETED CANCER THERAPY IN 2016:

  • bagony
  • 14 Slides

WHAT THE PRACTICING PATHOLOGIST OR ONCOLOGIST NEED...

KER/DAPI KER DAPI CD45 HER2

KER/DAPI KER DAPI CD45 HER2

  • projoutr
  • 1 Slides

A. B. C. D. 0. 1+. 2+. 3+. 3+. 3+. 3+.

20 March 2014EMACHMP1518532014Committee for Medicinal Products for

20 March 2014EMACHMP1518532014Committee for Medicinal Products for

  • nicole
  • 3 Slides

Adoptedby CHMPfor release for consultation20 March...

Best practice for chemotherapy for treatment of breast cancer

Best practice for chemotherapy for treatment of breast cancer

  • ariel
  • 42 Slides

Andreas Makris. Mount Vernon Cancer Center. Royal ...

Chemotherapeutic Treatment Options for Triple Negative Breast Cancer

Chemotherapeutic Treatment Options for Triple Negative Breast Cancer

  • iris
  • 30 Slides

Lauren Barney. April 17, 2013. Breast Cancer Subty...

Immunotherapy of Breast Cancer

Immunotherapy of Breast Cancer

  • WhereTheWildThingsAre
  • 27 Slides

World Congress on Breast Cancer . ...

Copyright © 2024 DocSlides. All Rights Reserved